Analysis of the T354P mutation of the sodium/iodide cotransporter gene in children with congenital hypothyroidism due to dyshormonogenesis

Authors
Hajar Miranzadeh-Mahabadi 1
Modjtaba Emadi-Baygi 2
Parvaneh Nikpour 3
Neda Mostofizade 4
Silva Hovsepian 5
Mahin Hashemipour 5
1 Department of Genetics, School of Basic Sciences, Shahrekord University, Shahrekord, Iran
2 Department of Genetics, School of Basic Sciences, Shahrekord University, Shahrekord; Institute of Biotechnology, School of Basic Sciences, Shahrekord University, Shahrekord, Iran
3 Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan; Department of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan; Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
5 Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan; Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Congenital hypothyroidism (CH) due to the thyroid dyshormonogenesis is more prevalent in Iran in comparison to other countries. Sodium iodide symporter (NIS) is one of the plasma membrane glycoproteins that is located on the basolateral side of thyroid follicular cells and mediates active I− trapping into these cells. Playing a prominent role in thyroid hormone synthesis, NIS gene mutations can be a cause of permanent CH with the etiology of dyshormonogenesis. The aim of this study was to investigate the occurrence of T354P mutation of the NIS gene, in a group of children affected with permanent CH in Isfahan.
Materials and Methods: Thirty-five patients with the etiology of dyshormonogenesis, and 35 healthy children, collected between 2002 and 2011 in Isfahan Endocrine and Metabolism Research Center, were examined for T354P mutation of the NIS gene by direct polymerase chain reaction-sequencing method.




Results: No T354P mutation was detected in any of the studied children.




Conclusions: More subjects with confirmed iodide transport defects should be screened for detecting the frequency of different reported NIS gene mutations in our population.

Keywords

1.
Klett M. Epidemiology of congenital hypothyroidism. Exp Clin Endocrinol Diabetes 1997;105 Suppl 4:19-23.  Back to cited text no. 1
    
2.
Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab 2007;91:268-77.  Back to cited text no. 2
    
3.
Hashemipour M, Amini M, Iranpour R, Sadri GH, Javaheri N, Haghighi S, et al. Prevalence of congenital hypothyroidism in Isfahan, Iran: Results of a survey on 20,000 neonates. Horm Res 2004;62:79-83.  Back to cited text no. 3
    
4.
Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis 2010;5:17.  Back to cited text no. 4
    
5.
Park SM, Chatterjee VK. Genetics of congenital hypothyroidism. J Med Genet 2005;42:379-89.  Back to cited text no. 5
    
6.
Foley T. Congrnital hypothroidism. In: Braverman L, Utiger R, editors. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 1996. p. 988-94.  Back to cited text no. 6
    
7.
Toublanc JE. Comparison of epidemiological data on congenital hypothyroidism in Europe with those of other parts in the world. Horm Res 1992;38:230-5.  Back to cited text no. 7
    
8.
Ilicki A, Larsson A, Karlsson FA. Circulating thyroid antibodies in congenital hypothyroidism. Acta Paediatr Scand 1991;80:805-11.  Back to cited text no. 8
    
9.
Azizi F, Sheikholeslam R, Hedayati M, Mirmiran P, Malekafzali H, Kimiagar M, et al. Sustainable control of iodinedeficiency in Iran: Beneficial results of the implementation of the mandatory law on salt iodization. J Endocrinol Invest 2002;25:409-13.  Back to cited text no. 9
    
10.
Hashemipoor M, Amini M, Gheisari A, Sharifei S, Iranpour R, Aminorroaya A. Comparison of urinary iodine excretion in neonates and their mothers in Isfahan, Iran. Endocr Pract 2002;8:347-50.  Back to cited text no. 10
    
11.
Van Vliet G. Development of the thyroid gland: Lessons from congenitally hypothyroid mice and men. Clin Genet 2003;63:445-55.  Back to cited text no. 11
    
12.
Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, Lazarus JH, et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 1998;19:399-401.  Back to cited text no. 12
    
13.
Congdon T, Nguyen LQ, Nogueira CR, Habiby RL, Medeiros-Neto G, Kopp P. A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: Evidence for phenotypic variability in mother and child. J Clin Endocrinol Metab 2001;86:3962-7.  Back to cited text no. 13
    
14.
Meeus L, Gilbert B, Rydlewski C, Parma J, Roussie AL, Abramowicz M, et al. Characterization of a novel loss of function mutation of PAX8 in a familial case of congenital hypothyroidism with in-place, normal-sized thyroid. J Clin Endocrinol Metab 2004;89:4285-91.  Back to cited text no. 14
    
15.
Borck G, Topaloglu AK, Korsch E, Martiné U, Wildhardt G, Onenli-Mungan N, et al. Four new cases of congenital secondary hypothyroidism due to a splice site mutation in the thyrotropin-beta gene: Phenotypic variability and founder effect. J Clin Endocrinol Metab 2004;89:4136-41.  Back to cited text no. 15
    
16.
Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 1997;138:3555-8.  Back to cited text no. 16
    
17.
Spitzweg C, Morris JC. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol 2010;322:56-63.  Back to cited text no. 17
    
18.
De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology. Physiol Rev 2000;80:1083-105.  Back to cited text no. 18
    
19.
Mostofizade N, Nikpour P, Javanmard SH, Emadi-Baygi M, Miranzadeh-Mahabadi H, Hovsepian S, et al. The G395R mutation of the Sodium/Iodide symporter (NIS) gene in patients with dyshormonogenetic congenital hypothyroidism. Int J Prev Med 2013;4:57-62.  Back to cited text no. 19
[PUBMED]  Medknow Journal  
20.
Fujiwara H, Tatsumi K, Miki K, Harada T, Miyai K, Takai S, et al. Congenital hypothyroidism caused by a mutation in the Na+/I- symporter. Nat Genet 1997;16:124-5.  Back to cited text no. 20
[PUBMED]    
21.
Fujiwara H, Tatsumi K, Miki K, Harada T, Okada S, Nose O, et al. Recurrent T354P mutation of the Na+/I- symporter in patients with iodide transport defect. J Clin Endocrinol Metab 1998;83:2940-3.  Back to cited text no. 21
    
22.
Kosugi S, Sato Y, Matsuda A, Ohyama Y, Fujieda K, Inomata H, et al. High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures. J Clin Endocrinol Metab 1998;83:4123-9.  Back to cited text no. 22
    
23.
Spitzweg C, Morris JC. The sodium iodide symporter: Its pathophysiological and therapeutic implications. Clin Endocrinol (Oxf) 2002;57:559-74.  Back to cited text no. 23
Advanced Biomedical Research
Volume 2016, April
April 2016
Pages 1-4